BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
362 results:

  • 1. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
    Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
    [No Abstract]    [Full Text] [Related]  

  • 2. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non-metastatic stage T4 nasopharyngeal carcinoma in IMRT era.
    Zheng Y; Xue F; Ou D; Niu X; Hu C; He X
    Cancer Med; 2024 Feb; 13(4):e6578. PubMed ID: 38457191
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
    Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
    Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
    Song Y; Jin Z; Li ZM; Liu Y; Li L; He C; Su H; Zhou H; Li K; Hao S; Zuo X; Wu J; Li D; Wu M; Sun X; Qi J; Cai Z; Li Z; Li Y; Huang Y; Shen J; Xiao Z; Zhu J
    Clin Cancer Res; 2024 Apr; 30(7):1248-1255. PubMed ID: 38190117
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imaging diagnosis and efficacy monitoring by [
    He H; Qi X; Fu H; Xu J; Zheng Q; Chen L; Zhang Y; Hua H; Xu W; Xu Z; Chen X; You Q; Lin J; Huang G; Mao Y; Yu C
    Theranostics; 2024; 14(1):392-405. PubMed ID: 38164149
    [No Abstract]    [Full Text] [Related]  

  • 7. Necrotizing apoptosis-related genes prognosis and treatment effect analysis of osteosarcoma in children.
    Chen Y; Wu L; Li Y; Zheng J; Zhong S; Gu S; Chen J
    J Gene Med; 2024 Jan; 26(1):e3646. PubMed ID: 38100138
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of mitochondrial-related signature and molecular subtype for the prognosis of osteosarcoma.
    Zhao X; Zhang J; Liu J; Chen Q; Cai C; Miao X; Wu T; Cheng X
    Aging (Albany NY); 2023 Nov; 15(22):12794-12816. PubMed ID: 37976137
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk factors for distant metastasis of Chondrosarcoma in the middle-aged and elderly people.
    Deng GH
    Medicine (Baltimore); 2023 Nov; 102(44):e35562. PubMed ID: 37932996
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline.
    Guninski RS; Cuccia F; Alongi F; Andratschke N; Belka C; Bellut D; Dahele M; Josipovic M; Kroese TE; Mancosu P; Minniti G; Niyazi M; Ricardi U; Munck Af Rosenschold P; Sahgal A; Tsang Y; Verbakel WFAR; Guckenberger M
    Radiother Oncol; 2024 Jan; 190():109969. PubMed ID: 37922993
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Assessing survival outcomes and complication profiles following surgical excision and radiotherapy as interventions for skull base chordoma: a systematic review of operative margins and surgical approaches.
    Brown NJ; Gendreau J; Kuo CC; Nguyen O; Yang C; Catapano JS; Lawton MT
    J Neurooncol; 2023 Oct; 165(1):41-51. PubMed ID: 37880419
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer.
    Tong Y; Xu S; Jiang L; Zhao C; Zhao D
    Front Endocrinol (Lausanne); 2023; 14():1266679. PubMed ID: 37867528
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma.
    Du J; Yuan X
    Eur J Pediatr; 2024 Jan; 183(1):185-202. PubMed ID: 37855927
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer.
    Goktas Aydin S; Bilici A; Calis E; Kutlu Y; Hamdard J; Muglu H; Fatih Olmez O; Karci E; Acikgoz O
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110947. PubMed ID: 37742369
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities.
    Basoli S; Cosentino M; Traversari M; Manfrini M; Tsukamoto S; Mavrogenis AF; Bordini B; Donati DM; Errani C
    Curr Oncol; 2023 Jul; 30(7):7043-7054. PubMed ID: 37504371
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of Baseline
    Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
    J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
    Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
    Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma.
    Liu X; Cao D; Liu H; Ke X; Liu X; Xu X
    Clin Transl Oncol; 2024 Jan; 26(1):214-224. PubMed ID: 37351807
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel.
    Modonutti D; Majdalany SE; Butaney M; Davis MJ; Corsi N; Sood A; Trinh QD; Cole AP; Rogers CG; Novara G; Abdollah F
    Prostate; 2023 Sep; 83(13):1238-1246. PubMed ID: 37290911
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The effect of central lymph node dissection on the prognosis of cN0 papillary thyroid microcarcinoma: a mid-term follow-up study.
    Xie X; Deng J; Zheng B; Zhong L; Miao J
    BMC Endocr Disord; 2023 May; 23(1):125. PubMed ID: 37248461
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.